Upload Image (Max 20MB per Image)
US-based Biomedical Advanced Research and Development Authority (BARDA) has granted $50.2m to Elusys Therapeutics for the development of investigational ETI-204 (Anthim) agent, designed for the treatment of inhalational anthrax following a ...
Tags: ETI-204, Posillico, Elusys